COPD

Improved survival rates suggest long-term noninvasive therapy (LTH-NIV) may benefit patients with acute hypercapnic exacerbations of chronic obstructive pulmonary disorder (AECOPD).

People with chronic obstructive pulmonary disease (COPD) are at increased risk of long-term hearing loss, researchers find.

Using gene enrichment analysis, a genome-wide association study (GWAS) identified a strong association with chronic obstructive pulmonary disease (COPD) and multiple ancestry groups.

The Assessment of Burden Chronic Conditions (ABCC) tool adds validity when measuring burden of disease among people with chronic conditions, according to one study.

Spirometry could aid physicians in identifying patients with chronic obstructive pulmonary disease (COPD) that are at high risk of cardiovascular disease, a study finds.

The device, PEP Buddy improves breathlessness symptoms and quality of life in patients with chronic obstructive pulmonary disease (COPD), as well as people who have anxiety and stress.

The prevalence of comorbidities in patients with severe chronic obstructive pulmonary disease (COPD), including impaired kidney function, are predictors of long-term mortality, study finds.

A combination of evidence-based interventions and team-based approaches shows efficacy in helping physicians care for patients with chronic obstructive pulmonary disease (COPD), according to one study.

A diagnostic algorithm was evaluated for its ability to gauge the presence of asthma or chronic obstructive pulmonary disease (COPD), in a new analysis.

Imaging and clinical characteristics reach high diagnostic efficacy when they are used to identify frequent acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).

The CAPTURE screening tool showed high specificity but low sensitivity in identifying primary care patients with previously undiagnosed chronic obstructive pulmonary disease (COPD).

Gender-specific chronic obstructive pulmonary disease (COPD) symptoms identify differences among men and women as good predictors for cardiac comorbidities.

A study of patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbation found that exclusively using the population-based Hospital Frailty Risk Score tool to assess for frailty may cause it to go undetected and untreated.

Compared with patients with poor continuous positive airway pressure (CPAP) compliance, patients with good CPAP compliance saw improvements in lung function after 12 months.

Multiple studies suggest that the mechanisms of lung damage and chronic obstructive pulmonary disease (COPD) due to biomass smoke differ from COPD caused by smoking cigarettes.

Patients with chronic obstructive pulmonary disease (COPD) are more likely to die in the year after undergoing surgery and rack up higher health care costs post-operation, study finds.

Adding air purifiers into the home directly improves cardiac autonomic function and respiratory health for patients living with chronic obstructive pulmonary disease (COPD).

Despite chronic obstructive pulmonary disease (COPD) being associated with poor mental health and depression, most older adults report being free of mental illness or substance abuse, a new study has found.

This year’s most-read articles on chronic obstructive pulmonary disease (COPD) includes researchon early interventions and possible health policy solutions.

New study findings call into question the necessity of spirometry as a criterion for participation in palliative care research among patients with chronic obstructive pulmonary disease (COPD).

Higher mortality rates linked with chronic obstructive pulmonary disease (COPD) are found in individuals employed in the mining and food service industries, according to a CDC analysis.

Key opinion leaders highlight the triple therapy approach from the most recent GOLD guidelines, including ICS, long-acting beta-agonist (LABA), and long-acting muscarinic antagonist (LAMA).

Inhaled corticosteroids (ICSs) are a key incorporation to COPD treatment strategies.

The role of combination therapy is explored for the treatment of COPD.

Social determinants of health (SDoH) can create major barriers for access to care.

The findings suggest that treatment with fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) led to improvements and had a similar safety profile to both FF/VI and UMEC/VI regardless of patient chronic mucus hypersecretion status at baseline.

Global health policy should consider the impact of breathlessness symptoms in adults when addressing increasing rates of obesity, according to a recent study.

Social and economic burdens affecting patients with COPD provide significant obstacles to optimizing care.

Jeffrey D. Dunn, PharmD, MBA, leads a panel discussion on disease and treatment landscapes for COPD.

A risk prediction model may offer insight in evaluating depression and anxiety in patients with chronic obstructive pulmonary disease (COPD).